Approval odds · by condition

SSDI approval odds for neoplasms (cancer).

In SSA research on 1997–2004 claims, about 81% of neoplasms (cancer) claims were allowed at the initial level, and roughly 89%were ultimately allowed once appeals are counted. Here’s how claims like these move through the system — and where they fare best.

Historical allowance rate · by primary diagnosis

81%

allowed at the initial level

~89%

ultimately allowed once appeals are counted

SSA research on 1997–2004 applications (Meseguer, Social Security Bulletin 73(2), 2013). Rates vary by primary diagnosis; these are older than the current-year stage rates below and describe the historical record, not any one claim.

Neoplasms (cancer) account for 6.5% of all SSDI awards (51,283 awards in the latest SSA annual report) — a measure of how common the condition is among awards, not the chance of approval.

National allowance rate by stage · FY2024

Initial application30.8%
Reconsideration12.1%
Hearing46.5%

The hearing stage is where the most denied claims turn into allowances — a denial earlier in the process is common and not the end of the road.

Estimate the odds for a specific case

Run the Approval-Odds Estimator

Pre-filled to neoplasms (cancer) — add state, age, and stage for the base rates that fit a real claim.

What SSA requires to approve a claim

The Blue Book criteria for cancer (malignant neoplasms)

The exact medical criteria SSA uses to allow these claims — in plain language, with the evidence each one needs.

Neoplasms (cancer) odds by state

Free case review

Wondering if you'd qualify with neoplasms (cancer)?

A disability attorney can tell you whether it's worth filing or appealing based on your situation. No cost to talk — most only get paid if you win.

Other conditions

Source: SSA public datasets (ALJ dispositions + Annual Statistical Report) · Updated 2026-06-18. Per-condition allowance rates are from SSA research on 1997–2004 claims (Meseguer, Social Security Bulletin 73(2), 2013). Not legal advice. Figures are SSA historical aggregates — award shares and national allowance rates by stage are current; the per-condition rates are older research. Individual outcomes turn on the medical evidence and the specific record.